Page last updated: 2024-08-22

helium and 2019 Novel Coronavirus Disease

helium has been researched along with 2019 Novel Coronavirus Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Feldman, LC; Kasaei, L; Kolloli, A; Kumar, R; Merolli, A; Ramasamy, S; Subbian, S1
Bykov, VI; Chuchalin, AG; Gavrilov, PV; Panin, AA; Petrikov, SS; Ryabokon, AM; Shogenova, LV; Tsybenova, SB; Utkina, II; Varfolomeev, SD; Zhuravel, SV1

Trials

1 trial(s) available for helium and 2019 Novel Coronavirus Disease

ArticleYear
Thermovaccination - thermoheliox as a stimulator of the immune response. Kinetics of the synthesis of antibodies and C-reactive protein in coronavirus infection.
    Chemico-biological interactions, 2021, Jan-25, Volume: 334

    Topics: Administration, Inhalation; Adult; Aged; Antibodies, Viral; C-Reactive Protein; COVID-19; Helium; Hot Temperature; Humans; Hyperthermia, Induced; Immunoglobulin G; Immunoglobulin M; Kinetics; Middle Aged; Models, Immunological; Oxygen; SARS-CoV-2; Vaccination

2021

Other Studies

1 other study(ies) available for helium and 2019 Novel Coronavirus Disease

ArticleYear
An intra-cytoplasmic route for SARS-CoV-2 transmission unveiled by Helium-ion microscopy.
    Scientific reports, 2022, 03-08, Volume: 12, Issue:1

    Topics: Angiotensin-Converting Enzyme 2; Animals; Chlorocebus aethiops; COVID-19; Cytoplasm; Extracellular Vesicles; Giant Cells; Helium; Humans; Ions; Microscopy; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Internalization

2022